eFFECTOR Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
eFFECTOR Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q1 2024.
  • eFFECTOR Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $225K, a 132% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $225K +$128K +132% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $53K -$58K -52.3% Dec 31, 2023 10-Q 2024-05-09
Q3 2023 $68K -$57K -45.6% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $83K -$56K -40.3% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $97K -$56K -36.6% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $111K -$55K -33.1% Dec 31, 2022 10-K 2024-03-26
Q3 2022 $125K +$101K +421% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $139K +$92K +196% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $153K Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $166K +$74K +80.4% Dec 31, 2021 10-K 2023-03-08
Q3 2021 $24K Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $47K Jun 30, 2021 8-K 2021-08-31
Q4 2020 $92K Dec 31, 2020 10-K 2022-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.